# OnCo record salvatore-siena (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/salvatore-siena/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "salvatore-siena" ;
  schema:name "Salvatore Siena"@en ;
  schema:description "Milan oncologist who co-led HERACLES and was lead author of DESTINY-CRC01, which showed trastuzumab deruxtecan is active in HER2-positive colorectal cancer, and a leader of the anti-EGFR antibody trials in the disease."@en ;
  schema:url <https://onco.cc/people/salvatore-siena/> ;
  schema:dateModified "2026-09-18"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Salvatore_Siena>, <https://orcid.org/0000-0002-2681-2846> ;
  onco:tag "colorectal", "targeted-therapy", "trialist" ;
  schema:jobTitle "Professor of Medical Oncology, University of Milan, and Niguarda Cancer Center" ;
  onco:cancers <https://onco.cc/cancers/her2-amplified-colorectal/>, <https://onco.cc/cancers/colorectal/> ;
  onco:institutions <https://onco.cc/institutions/niguarda-cancer-center/> ;
  onco:trials <https://onco.cc/trials/heracles/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-destiny-crc01-lancet-oncol-2021/> ;
  schema:affiliation <https://onco.cc/institutions/niguarda-cancer-center/> .